SEGALL BRYANT & HAMILL, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
SEGALL BRYANT & HAMILL, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,231,539
+11.8%
137,925
+46.0%
0.05%
+22.5%
Q2 2023$3,784,372
+98502.7%
94,444
+0.4%
0.04%
-2.4%
Q1 2023$3,838
+7.0%
94,047
+1.3%
0.04%
+2.5%
Q4 2022$3,586
-99.9%
92,882
+7.4%
0.04%
-27.3%
Q3 2022$4,598,000
-6.9%
86,454
+2.0%
0.06%
-1.8%
Q2 2022$4,940,000
+8.5%
84,743
+42.0%
0.06%
+27.3%
Q1 2022$4,553,000
+27.1%
59,665
+0.3%
0.04%
+33.3%
Q4 2021$3,581,000
-43.7%
59,516
-47.6%
0.03%
+6.5%
Q3 2021$6,356,000
+71.1%
113,488
+85.3%
0.03%
-13.9%
Q2 2021$3,715,000
-9.5%
61,234
+4.7%
0.04%
-12.2%
Q1 2021$4,103,000
+16.7%
58,512
-0.4%
0.04%
+5.1%
Q4 2020$3,517,000
-2.1%
58,771
-1.6%
0.04%
-20.4%
Q3 2020$3,592,000
+229.8%
59,748
+188.2%
0.05%
+172.2%
Q2 2020$1,089,000
+60.4%
20,730
+2.2%
0.02%
+28.6%
Q1 2020$679,000
-31.1%
20,279
-6.6%
0.01%
-6.7%
Q4 2019$985,000
+12.8%
21,723
-5.1%
0.02%
+7.1%
Q3 2019$873,000
-10.8%
22,901
+1.7%
0.01%
-6.7%
Q2 2019$979,000
+52.3%
22,529
+33.2%
0.02%
+50.0%
Q1 2019$643,000
-9.3%
16,910
+2.6%
0.01%
-16.7%
Q4 2018$709,000
-13.2%
16,477
-0.9%
0.01%0.0%
Q3 2018$817,000
+53.0%
16,619
-0.3%
0.01%
+50.0%
Q2 2018$534,00016,6710.01%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 251,140$19,167,0008.83%
GAGNON SECURITIES LLC 610,933$46,626,0007.60%
Tamarack Advisers, LP 205,000$15,646,0007.40%
Spyglass Capital Management LLC 1,871,040$142,798,0004.88%
Lisanti Capital Growth, LLC 302,413$23,080,0002.59%
Rock Springs Capital Management LP 1,000,000$76,320,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 208,197$15,890,0001.76%
JABODON PT CO 49,052$3,744,0001.70%
Zweig-DiMenna Associates LLC 166,675$12,721,0001.70%
NEUMEIER POMA INVESTMENT COUNSEL LLC 317,425$24,226,0001.63%
View complete list of PACIRA PHARMACEUTICALS INC shareholders